Healthcare provider profile · identity verified

Martin Daniel Mcdermott, M.D.

Family Practice · FORT LUPTON, CO · NPI 1699784181

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	261	75
Atorvastatin Calcium	Atorvastatin Calcium	253	78
Oxycodone Hcl	Oxycodone Hcl	253	21
Gabapentin	Gabapentin	235	61
Tramadol Hcl	Tramadol Hcl	205	47
Rosuvastatin Calcium	Rosuvastatin Calcium	199	62
Tamsulosin Hcl	Tamsulosin Hcl	197	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	191	23
Lisinopril	Lisinopril	167	58
Metoprolol Succinate	Metoprolol Succinate	148	46
Metformin Hcl Er	Metformin Hcl	142	47
Pioglitazone Hcl	Pioglitazone Hcl	137	41
Zolpidem Tartrate	Zolpidem Tartrate	136	22
Amlodipine Besylate	Amlodipine Besylate	116	41
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	115	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	25
Simvastatin	Simvastatin	106	32
Metformin Hcl	Metformin Hcl	101	37
Furosemide	Furosemide	99	33
Montelukast Sodium	Montelukast Sodium	99	33
Spironolactone	Spironolactone	99	30
Losartan Potassium	Losartan Potassium	97	30
Tizanidine Hcl	Tizanidine Hcl	96	25
Omeprazole	Omeprazole	94	32
Albuterol Sulfate Hfa	Albuterol Sulfate	86	33
Alprazolam	Alprazolam	85	14
Hydrochlorothiazide	Hydrochlorothiazide	79	27
Finasteride	Finasteride	78	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	76	28
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	75	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	18
Lorazepam	Lorazepam	67	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	64	40
Pantoprazole Sodium	Pantoprazole Sodium	63	25
Hydroxyzine Hcl	Hydroxyzine Hcl	61	19
Dutasteride	Dutasteride	59	18
Duloxetine Hcl	Duloxetine Hcl	58	16
Carvedilol	Carvedilol	53	21
Oxybutynin Chloride Er	Oxybutynin Chloride	53	17
Xarelto	Rivaroxaban	53	suppressed
Eliquis	Apixaban	52	12
Metoprolol Tartrate	Metoprolol Tartrate	52	19
Clopidogrel	Clopidogrel Bisulfate	49	15
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Pregabalin	Pregabalin	49	16
Azithromycin	Azithromycin	46	37
Allopurinol	Allopurinol	44	14
Buspirone Hcl	Buspirone Hcl	44	suppressed
Januvia	Sitagliptin Phosphate	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	35
Fluticasone Propionate	Fluticasone Propionate	41	20
Clonazepam	Clonazepam	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	19
Farxiga	Dapagliflozin Propanediol	40	suppressed
Doxepin Hcl	Doxepin Hcl	37	14
Olmesartan Medoxomil	Olmesartan Medoxomil	37	11
Trazodone Hcl	Trazodone Hcl	37	11
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Potassium Chloride	Potassium Chloride	36	11
Candesartan Cilexetil	Candesartan Cilexetil	34	12
Estradiol	Estradiol	34	12
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	29
Baclofen	Baclofen	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Prednisone	Prednisone	30	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Diazepam	Diazepam	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Ondansetron Odt	Ondansetron	28	14
Ozempic	Semaglutide	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	19
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	11
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Temazepam	Temazepam	27	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Fluconazole	Fluconazole	26	17
Jardiance	Empagliflozin	26	suppressed
Methylprednisolone	Methylprednisolone	26	19
Bupropion Xl	Bupropion Hcl	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Famotidine	Famotidine	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Atenolol	Atenolol	21	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	20	suppressed
Cephalexin	Cephalexin	20	16
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Mupirocin	Mupirocin	20	11
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	20	15
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Valproic Acid	Valproic Acid	17	suppressed
Tradjenta	Linagliptin	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Silodosin	Silodosin	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Albendazole	Albendazole	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pen Needles	Pen Needle, Diabetic	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Promacta	Eltrombopag Olamine	11	suppressed
Topiramate	Topiramate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Xeljanz Xr	Tofacitinib Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error